Neuphoria Therapeutics Inc.

NEUP | NASDAQ

Price Alert Chart Builder DCF Calculator

$3.05

-$0.01 (-0.33%)

At close: Oct 30, 2026, 4:00 PM ET

$3.05

$0.00 (0.00%)

After-hours: Oct 30, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2026 Jun 30, 2026	FY 2025 Jun 30, 2025	FY 2024 Jun 30, 2024	FY 2023 Jun 30, 2023	FY 2022 Jun 30, 2022	FY 2021 Jun 30, 2021
Net Income	-13.45B	-369.63M	-15.49M	-14.38M	-21.76M	-6.53M
Depreciation & Amortization	662.96M	662.89M	662.99K	446.09K	1.11M	1.28M
Stock-Based Compensation	351.6M	163.77M	814.81K	n/a	2.83M	983.01K
Other Working Capital	-2.48M	305.9K	351.28K	49.18K	228.85K	-294.75K
Other Non-Cash Items	227.53M	89.12M	-2.12M	1.01M	1.67M	-2.62M
Deferred Income Tax	-139.17M	-468.43M	n/a	n/a	n/a	n/a
Change in Working Capital	-4.05M	-496.83K	1.46M	3.08M	-5.6M	1.23M
Operating Cash Flow	-12.35B	77.23M	-14.68M	-9.85M	-21.75M	-5.66M
Capital Expenditures	4	n/a	n/a	n/a	-1.54K	-1.1K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	-89.01K
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	435.59K	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	187.59K	29.85K
Investing Cash Flow	n/a	n/a	n/a	n/a	621.64K	-60.26K
Debt Repayment	n/a	n/a	n/a	n/a	-174.2K	-8.92M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	17.9B	1.53B	5M	n/a	-5.72M	-312.17K
Financial Cash Flow	17.92B	1.53B	15.11M	5.81M	26.99M	23.71M
Net Cash Flow	5.58B	1.6B	504.99K	-15.02M	5.06M	17.97M
Free Cash Flow	-12.35B	77.23M	-14.68M	-9.85M	-21.75M	-5.67M
Adj. Free Cash Flow	-12.7B	-86.54M	-15.5M	-9.85M	-24.58M	-6.65M
Maintenance CapEx	4	n/a	n/a	n/a	-1.54K	n/a
Growth CapEx	n/a	n/a	n/a	n/a	n/a	-1.1K
Owner Earnings	-12.35B	77.23M	-14.68M	-9.85M	-21.75M	-5.66M